SOURCE: IBC Life Sciences

June 24, 2008 11:30 ET

IBC's 8th Annual Formulation Strategies for Protein Therapeutics Conference

A Must Attend Meeting for Formulation, Delivery and Analytical Development Scientists From Biotherapetic Development Organizations From Around the World

WESTBOROUGH, MA--(Marketwire - June 24, 2008) - IBC Life Sciences is pleased to present the 8th annual Formulation Strategies for Protein Therapeutics conference on September 23-25, 2008 at the Disneyland Hotel in Anaheim, California. The conference will be co-located with the BioProcess International Conference & Exhibition (September 23-26, 2008). The Formulation conference features three full days of solution-oriented presentations with topics determined through the input of formulation scientists from research organizations around the world.

The 2008 program will help attendees:

--  Understand how to optimize formulations for pre-filled syringe
    products from early development through commercialization with strategies
    from Amgen, Biogen-Idec, Human Genome Sciences, West Pharmaceutical
    Services and the U.S. Food and Drug Administration
--  Learn how to design quality into protein therapeutics from the start
    in an panel, "The QbD Pioneers: Perspectives from Companies that have
    Implemented Quality by Design Concepts in Formulation Development"
--  Overcome the challenges of formulating high concentration proteins --
    with case studies from Abbott Laboratories, Amgen, Genentech, Roche and
    Wyeth
--  Benchmark their formulation operations in facilitated small group Best
    Practices Exchange for formulation scientists
    

Keynote Presentations:

--  Integrating Market Drivers in Drug Product Development and Lifecycle
    Management
    Anthony B. Barry, Ph.D., Principal Research Scientist, Drug Product
    Development, Wyeth BioPharma
--  Identifying Critical Product Attributes and Developing the Design
    Space for Protein Formulations
    Joseph Phillips, Ph.D., Executive Director, Formulation and Analytical
    Development, Amgen
    

Complete details on this event can be found at www.IBCLifeSciences.com/formulation

About IBC Life Sciences

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: http://www.IBCLifeSciences.com.

Contact Information

  • Contact:
    Dawn O'Connor
    IBC Life Sciences
    508-614-1679
    Email Contact